Researchers in Osaka have found that stem cells from fat tissue can repair spinal fractures similar to those caused by osteoporosis. By turning these cells into bone-forming clusters and pairing them with a bone-rebuilding material, rats regained stronger, healthier spines. The approach could offer a safe, minimally invasive alternative for treating bone diseases in humans.

Japanese researchers uncovered a universal rule describing why life’s growth slows despite abundant nutrients. Their “global constraint principle” integrates classic biological laws to show that multiple factors limit cellular growth in sequence. Verified through E. coli simulations, it provides a powerful new lens for studying living systems. The work could boost crop yields and biomanufacturing efficiency.

Researchers found that runners who sleep poorly face nearly double the injury risk compared to those who rest well. The study highlights that sleep is not just recovery—it’s a key factor in preventing injuries. They stress that runners should prioritize rest alongside training. Simple habits like consistent bedtimes and limiting screens can make a big difference.

Japanese researchers found that lecanemab, an amyloid-clearing drug for Alzheimer’s, does not improve the brain’s waste clearance system in the short term. This implies that nerve damage and impaired clearance occur early and are difficult to reverse. Their findings underscore that tackling amyloid alone may not be enough to restore brain function, urging a broader approach to treatment.

Researchers identified SGK1 as a key chemical connecting childhood trauma to depression and suicidal behavior. High SGK1 levels were found in the brains of suicide victims and in people with genetic variants linked to early adversity. Drugs that block SGK1 could offer a new kind of antidepressant, especially for patients resistant to SSRIs.

Scientists have found that keratin, the protein in hair and skin, can repair and protect tooth enamel. The material forms a mineralized layer that halts decay and restores strength, outperforming traditional fluoride. Made from sustainable sources like hair, it could soon be available in toothpaste or gels. The discovery could transform dentistry by turning waste into a powerful tool for regeneration.

Researchers have discovered that prostate cancer depends on two key enzymes, PDIA1 and PDIA5, to survive and resist therapy. When blocked, these enzymes cause the androgen receptor to collapse, killing cancer cells and enhancing the effects of drugs like enzalutamide. They also disrupt the cancer’s energy system, striking it on multiple fronts. This breakthrough could open a new path to overcoming drug resistance in advanced prostate cancer.

A sweeping review of existing studies finds no solid evidence that using acetaminophen (Tylenol) during pregnancy increases the risk of autism or ADHD in children. Researchers found that previous reviews often relied on weak or biased data, and most did not properly account for genetic or environmental factors shared by families. When these factors were considered, any apparent link between acetaminophen use and neurodevelopmental disorders largely disappeared.

In Peru’s mysterious Pisco Valley, thousands of perfectly aligned holes known as Monte Sierpe have long puzzled scientists. New drone mapping and microbotanical analysis reveal that these holes may once have served as a bustling pre-Inca barter market—later transformed into an accounting system under the Inca Empire.

New research finds that daily coffee drinking may cut AFib risk by nearly 40%, defying decades of medical caution. Scientists discovered that caffeine’s effects on activity, blood pressure, and inflammation could all contribute to a healthier heart rhythm. The DECAF clinical trial’s findings suggest coffee could be not only safe but beneficial for people with A-Fib.

Intermountain Health researchers discovered that customizing vitamin D3 doses for heart attack survivors slashed their risk of another heart attack by 50%. The strategy involved frequent monitoring and dose adjustments to reach ideal vitamin D levels. Traditional studies didn’t track blood levels, missing this critical link.

XRISM’s observations of GX13+1 revealed a slow, fog-like wind instead of the expected high-speed blast, challenging existing models of radiation-driven outflows. The discovery hints that temperature differences in accretion discs may determine how energy shapes the cosmos.

New research from UBC Okanagan mathematically demonstrates that the universe cannot be simulated. Using Gödel’s incompleteness theorem, scientists found that reality requires “non-algorithmic understanding,” something no computation can replicate. This discovery challenges the simulation hypothesis and reveals that the universe’s foundations exist beyond any algorithmic system.

Scientists have discovered that most chronic fatigue patients experience dysfunctional breathing, which may worsen their symptoms. The likely culprit is dysautonomia, a disruption in how the body controls blood vessels and muscles. Breathing retraining, yoga, or biofeedback could help restore proper breathing rhythm and ease fatigue. The findings open a promising new path for managing this long-misunderstood illness.

Researchers from the University of Vienna discovered MISO bacteria that use iron minerals to oxidize toxic sulfide, creating energy and producing sulfate. This biological process reshapes how scientists understand global sulfur and iron cycles. By outpacing chemical reactions, these microbes could help stop the spread of oceanic dead zones and maintain ecological balance.

A Japanese-led research team has developed AUN, a groundbreaking immune-independent bacterial cancer therapy that uses two harmonized bacteria to destroy tumors even in patients with weakened immune systems. By leveraging the natural synergy between Proteus mirabilis and Rhodopseudomonas palustris, AUN selectively targets cancer cells, reshapes itself within tumors, and avoids harmful side effects like cytokine release syndrome.

A new blood pressure calculator built on extensive clinical trial data helps doctors accurately estimate how much each medication will reduce blood pressure. The tool simplifies complex treatment choices and replaces unreliable BP measurements with solid evidence.

Scientists have turned to advanced AI to decode the intricate ecosystem of gut bacteria and their chemical signals. Using a Bayesian neural network called VBayesMM, researchers can now identify genuine biological links rather than random correlations. The system has already outperformed traditional models in studies of obesity, sleep disorders, and cancer.

A hospital in Thailand created a quick-action dialysis protocol for patients with metformin-associated lactic acidosis, a dangerous reaction to a common diabetes drug. The program sharply reduced deaths and sped up treatment times. Awareness also soared, showing how organized emergency pathways can transform patient outcomes.

Millions struggle with depression and anxiety, often enduring long waits for effective treatment. Scientists in Sweden, Denmark, and Germany are developing a genetic test to predict which medications will actually work. Using polygenic risk scores, they can analyze DNA variations linked to mental health and drug response.